HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ulrich Germing Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

7/2015Change of prognosis of patients with myelodysplastic syndromes during the last 30 years.
12/2013Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
11/2007Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.
12/2006Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
1/2006Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.
2/2004Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ulrich Germing Research Topics

Disease

45Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2015 - 10/2002
22Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2015 - 11/2002
7Neoplasms (Cancer)
12/2015 - 10/2002
6Refractory Anemia with Excess of Blasts (RAEM)
07/2015 - 02/2004
6Chromosome Aberrations (Chromosome Abnormalities)
01/2012 - 01/2006
5Refractory Anemia
12/2015 - 10/2002
3Leukemia
12/2015 - 03/2009
3Graft vs Host Disease (Graft-Versus-Host Disease)
09/2012 - 11/2008
3Hematologic Neoplasms (Hematological Malignancy)
03/2009 - 10/2002
3Lymphoma (Lymphomas)
08/2006 - 11/2002
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
05/2015 - 05/2007
2Iron Overload
08/2012 - 11/2008
2Neutropenia
05/2011 - 01/2008
2Infection
05/2011 - 04/2003
2Occupational Diseases (Occupational Disease)
03/2009 - 08/2008
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2009 - 11/2002
1Juvenile Myelomonocytic Leukemia
01/2015
1Inflammation
12/2013
1Disease Progression
12/2013
1Fatigue
02/2013
1Thrombocytosis (Thrombocythemia)
07/2012
1Exanthema (Rash)
03/2012
1Multiple Myeloma
03/2012
1Anemia
10/2011
1Death (Near-Death Experience)
10/2011
1Eosinophilia
05/2010
1Thrombocytopenia (Thrombopenia)
11/2009
1Preleukemia
03/2009
1Aplastic Anemia (Anemia, Hypoplastic)
03/2009
1Rheumatic Diseases (Rheumatism)
01/2009
1Hematologic Diseases (Blood Diseases)
08/2008
1Myeloproliferative Disorders (Myeloproliferative Disorder)
05/2008
1Critical Illness (Critically Ill)
04/2008
1Sepsis (Septicemia)
04/2008
1Glycogen Storage Disease (Glycogenosis)
01/2008
1Down Syndrome (Down's Syndrome)
12/2007
1Acute Promyelocytic Leukemia
11/2007
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2006

Drug/Important Bio-Agent (IBA)

6Azacitidine (5 Azacytidine)FDA Link
04/2015 - 02/2010
4decitabine (5-aza-2'-deoxycytidine)FDA Link
12/2015 - 11/2009
4lenalidomide (CC 5013)FDA Link
01/2014 - 01/2006
4Ferritins (Ferritin)IBA
12/2013 - 11/2008
4Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
08/2011 - 09/2004
4Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2006 - 09/2004
35q- syndromeIBA
12/2013 - 12/2006
3Azathioprine (Imuran)FDA LinkGeneric
01/2009 - 05/2005
3Histone Deacetylases (Histone Deacetylase)IBA
01/2006 - 09/2004
2Hemoglobins (Hemoglobin)IBA
12/2013 - 10/2011
2IronIBA
12/2013 - 03/2012
2ProteomeIBA
05/2013 - 01/2007
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2012 - 05/2010
2CreatinineIBA
03/2012 - 06/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2012 - 08/2004
2monosomy Chromosome 7IBA
04/2010 - 01/2008
2tipifarnib (R115777)IBA
11/2009 - 05/2007
2Benzene (Benzole)IBA
03/2009 - 08/2008
2rituximab (Mabthera)FDA Link
08/2006 - 06/2004
1CalreticulinIBA
05/2015
1Transferrin Receptors (Transferrin Receptor)IBA
12/2013
1hepcidinIBA
12/2013
1C-Reactive ProteinIBA
12/2013
1Transferrin (beta 2 Transferrin)IBA
12/2013
1tranilast (N 5')IBA
12/2013
1ErythropoietinFDA Link
12/2013
1CalciumIBA
05/2013
1Fibrinogen (Factor I)FDA Link
05/2013
1Janus Kinase 2IBA
07/2012
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
03/2012
1mycophenolate mofetil (Cellcept)FDA LinkGeneric
03/2012
1Tacrolimus (Prograf)FDA LinkGeneric
03/2012
1deferasiroxFDA Link
03/2012
1N 30IBA
02/2012
1Carbon MonoxideIBA
03/2011
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
08/2010
1ribosomal protein S14IBA
10/2009
1First StepIBA
08/2009
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
02/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2009
1Mitochondrial DNA (mtDNA)IBA
05/2008
1Glucose-6-PhosphateIBA
01/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2008
1Severe congenital neutropeniaIBA
01/2008
1GlycogenIBA
01/2008
1Chromosome 21 monosomyIBA
12/2007
1arsenic trioxide (Trisenox)FDA Link
11/2007
1ArsenicIBA
11/2007
1Farnesyltranstransferase (Farnesyltransferase)IBA
05/2007
1imatinib (Gleevec)FDA Link
05/2007
1LigandsIBA
01/2007

Therapy/Procedure

13Stem Cell Transplantation
07/2015 - 10/2002
13Drug Therapy (Chemotherapy)
02/2013 - 10/2002
6Transplants (Transplant)
04/2015 - 10/2002
3Hematopoietic Stem Cell Transplantation
04/2015 - 05/2009
2Transplantation (Transplant Recipients)
01/2015 - 11/2008
2Cell Transplantation
02/2013 - 09/2012
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2008 - 04/2008
1Salvage Therapy
04/2015
1Activities of Daily Living (ADL)
02/2013
1Platelet Transfusion (Blood Platelet Transfusions)
11/2009
1Erythrocyte Transfusion
11/2008